Fibralign Corporation
Medtech · Private
BioBridge, a thread-like collagen scaffold device designed to regenerate lymphatic vessels and treat breast cancer-related lymphedema
fibralignbio.com →- Grants
- $4.9M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $3.3M
- 4 awards · Defense
- #160 of 4531 in medtech
- Patents
- 18
- 4 granted · 14 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201120132015201720192021
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Defense · SBIR Phase I A113-122-0438 | $1,149,886 | |
| Federal contract | Department of Defense · SBIR Phase I Dhp H141-009-0112 Igf::ot::igf | $150,000 | |
| Federal contract | Department of Defense · New Dhp SBIR Ph II Award. Igf::ot::igf | $987,971 | |
| Federal grant | Department of Health and Human Services · Phase II · Prospective evaluation of a surgical solution for breast cancer-associated lymphedema | $997,783 | |
| Federal grant | Department of Health and Human Services · Phase II · Prospective evaluation of a surgical solution for breast cancer-associated lymphedema | $2,965,714 | |
| Federal contract | Department of Defense · Dha Medical, R&d Contract SBIR 2ND Phase II, Proposal#: H2-0402, Titled, " Aligned Nanofibrillar Scaffold Activated With Hgf-mmrna In Combination With Minced Muscle Graft For Treating Volumetric Muscle Loss (vml) Injury" | $996,609 | |
| Federal grant | Department of Health and Human Services · Phase II · Prospective evaluation of a surgical solution for breast cancer-associated lymphedema | $1,695 | |
| Federal grant | Department of Health and Human Services · Phase II · Prospective evaluation of a surgical solution for breast cancer-associated lymphedema | $252,861 | |
| Federal grant | Department of Health and Human Services · Phase II · Prospective evaluation of a surgical solution for breast cancer-associated lymphedema | $32,935 | |
| Federal grant | Department of Health and Human Services · Phase II · Prospective evaluation of a surgical solution for breast cancer-associated lymphedema | $682,266 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 157 | INNOVATIVE DESIGN LABS INC | $3.3M | — |
| 158 | AUTONOMUS MEDICAL TECHNOLOGIES, INC. | $3.3M | — |
| 159 | DIGIRAD CORP | $3.3M | $3.0M |
| 160 | Fibralign Corporation | $3.3M | — |
| 161 | NEUWAVE MEDICAL, INC. | $3.3M | $51M |
| 162 | MIMOSA ACOUSTICS | $3.3M | — |
| 163 | NEUROFIT, INC. | $3.2M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Method And Device For Lymphedema Treatmentgranted
- Biocomposites And Methods Of Making The Samegranted
- Medical Device And Delivery Method Onto Offset Surface Of Mammal Tissuegranted
- Biocomposites And Methods Of Making The Samegranted
- Composition For Targeted Delivery Of Nucleic Acid-Based Therapeuticsapplication
- Devices And Methods For Edema Treatmentapplication
- Composition For Targeted Delivery Of Nucleic Acid-based Therapeuticsapplication
- Composition For Targeted Delivery Of Nucleic Acid Based Therapeuticsapplication
- Method And Device For Lymphedema Treatmentapplication
- Method And Device For Lymphedema Treatmentapplication
- Medical Device And Delivery Method Onto Offset Surface Of Mammal Tissueapplication
- Conductive Biopolymer Implant For Enhancing Tissue Repair And Regeneration Using Electromagnetic Fieldsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.